Rhumbline Advisers Molecular Templates, Inc. Transaction History

Rhumbline Advisers

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$0.39 - $0.54 $331 - $459	850 New	850 $0
Q2 2022 Aug 11, 2022	SELL	$0.81 - $3.43 $26,885 - $113,848	-33,192 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.27 - $4.13 $2,578 - $4,691	1,136 Added 3.54%	33,192 $115,000
Q4 2021 Feb 10, 2022	SELL	$3.37 - $6.87 $1,526 - $3,112	-453 Reduced 1.39%	32,056 $126,000
Q3 2021 Nov 12, 2021	BUY	$5.78 - $7.86 $7,750 - $10,540	1,341 Added 4.3%	32,509 $218,000
Q2 2021 Aug 05, 2021	BUY	$7.82 - $12.44 $20,206 - $32,144	2,584 Added 9.04%	31,168 $244,000
Q1 2021 May 06, 2021	SELL	$9.33 - $14.05 $18,426 - $27,748	-1,975 Reduced 6.46%	28,584 $361,000
Q4 2020 Feb 10, 2021	BUY	$8.48 - $12.23 $17,723 - $25,560	2,090 Added 7.34%	30,559 $287,000
Q3 2020 Nov 12, 2020	SELL	$9.99 - $14.41 $36,413 - $52,524	-3,645 Reduced 11.35%	28,469 $311,000
Q2 2020 Aug 13, 2020	BUY	$12.28 - $17.63 $111,723 - $160,397	9,098 Added 39.53%	32,114 $443,000
Q1 2020 May 06, 2020	BUY	$11.31 - $18.26 $36,146 - $58,358	3,196 Added 16.13%	23,016 $306,000
Q4 2019 Feb 05, 2020	BUY	$6.44 - $14.21 $1,107 - $2,444	172 Added 0.88%	19,820 $277,000
Q3 2019 Oct 23, 2019	BUY	$4.6 - $8.46 $3,408 - $6,268	741 Added 3.92%	19,648 $129,000
Q2 2019 Aug 14, 2019	BUY	$5.83 - $8.42 $27,208 - $39,296	4,667 Added 32.77%	18,907 $158,000
Q1 2019 May 01, 2019	BUY	$4.02 - $5.81 $4,482 - $6,478	1,115 Added 8.5%	14,240 $83,000
Q4 2018 Jan 31, 2019	BUY	$3.35 - $5.68 $43,968 - $74,550	13,125 New	13,125 $53,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.